# US 2013/0231302 A1 · Antimicrobial solutions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0231302 A1
- Document ID: US20130231302A1
- Status: Published application
- Kind: A1
- Application number: 13/821,546
- Filed: 2011-09-09
- Published: 2013-09-05
- Earliest claimed: 2010-09-10
- Assignees: Board of Regents, The University of Texas System
- Inventors: Issam Raad; George Abiaad
- Web page: https://patentgrep.com/patent/US20130231302A1

## CPC

- A01N 47/44: Guanidine; Derivatives thereof
- A01N 31/02: Acyclic compounds
- A01N 31/14: Ethers
- A01N 43/16: with oxygen as the ring hetero atom
- A61K 31/085: having an ether linkage to aromatic ring nuclear carbon
- A61K 31/155: Amidines ([IMAGE cpc-sch-A61K-1029.gif]), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A61K 31/715: Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61L 2/186: Peroxide solutions
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 2103/15: Laboratory, medical or dentistry appliances, e.g. catheters or sharps
- A61L 2300/206: Biguanides, e.g. chlorohexidine
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention provides antimicrobial solutions that in certain cases comprise a biguanide and a glycol ether and, in some cases, optionally also includes combinations of at least one an alcohol, at least one chelator, glycerol, deoxycholate, and/or at least one alkylpolyglucoside. In certain aspects the invention comprises a biguanide and deoxycholate or a combination of chelator, ethanol, and alkylpolyglucoside. Also provided are methods for rapidly killing and/or reducing bacteria, fungi, or virus from surfaces, for example, including surfaces of indwelling medical devices and organic surfaces such as skin and sutures, and inorganic surfaces such as medical equipment, pipelines etc.

## Claims

### Claim 1

An antimicrobial composition comprising at least one biguanide and at least one glycol ether.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising at least one of the following agents:
a) an alkylpolyglucoside, wherein the alkylpolyglucoside has the structure:
wherein R is an C2-C20 alkyl,
b) deoxycholate,
c) at least one chelator,
d) at least one alcohol, and/or
e) glycerol.

### Claim 3 (depends on 1)

The composition of claim 1, comprising a biguanide, a glycol ether, and an alkylpolyglucoside.

### Claim 4 (depends on 1)

The composition of claim 1, comprising a biguanide, a alkylpolyglucoside, a chelator, and an alcohol.

### Claim 5 (depends on 1)

The composition of claim 1, comprising a biguanide, a glycol ether, and deoxycholate.

### Claim 6 (depends on 1)

The composition of claim 1, comprising a biguanide, a glycol ether, an alkylpolyglucoside, and deoxycholate.

### Claim 7 (depends on 2)

The composition of claim 2, wherein R is a C4-C14 alkyl.

### Claim 8 (depends on 2)

The composition of claim 2, wherein the alkylpolyglucoside is selected from the group consisting of capryl glucoside, decyl glucoside, coco-glucoside, and lauryl glucoside.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the biguanide is selected from the group consisting of chlorhexidine, alexidine, hexamidine.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the glycol ether is dipropylene glycol n-butyl ether.

### Claim 11 (depends on 1)

The composition of claim 1, wherein the chelator is selected from the group of chelators consisting of EDTA free acid, EDTA 2Na, EDTA 3Na, EDTA 4Na, EDTA 2K, EDTA 2Li, EDTA 2NH4, EDTA 3K, Ba(II)-EDTA, Ca(II)-EDTA, Co(II)-EDTACu(II)-EDTA, Dy(III)-EDTA, Eu(III)-EDTA, Fe(III)-EDTA, In(III-EDTA, La(III)-EDTA, CyDTA, DHEG, diethylenetriamine penta acetic acid (DTPA), DTPA-OH, EDDA, EDDP, EDDPO, EDTA-OH, EDTPO, EGTA, HBED, HDTA, HIDA, IDA, Methyl-EDTA, NTA, NTP, NTPO, O-Bistren, TTHA, EGTA, DMSA, deferoxamine, dimercaprol, citrate, EDDS, HEIDA, sodium metabisulfite, zinc citrate, a combination of bismuth and citrate, penicillamine, succimer and Etidronate.

### Claim 12 (depends on 1)

The composition of claim 1, wherein the alcohol is selected from the group consisting of ethanol and isopropyl alcohol.

### Claim 13 (depends on 1)

The composition of claim 1, wherein the concentration of biguanide is about 0.01%-6%.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the concentration of dipropylene glycol n-butyl ether is about 1%-12%.

### Claim 15 (depends on 2)

The composition of claim 2, wherein the concentration of alkylpolyglucoside is about 0.1%-10%.

### Claim 16 (depends on 2)

The composition of claim 2, wherein the concentration of chelator is about 0.1%-20%.

### Claim 17 (depends on 2)

The composition of claim 2, wherein the concentration of alcohol is in the range of about 1%-80%.

### Claim 18 (depends on 2)

The composition of claim 2, wherein the concentration of alcohol is in the range of about 15-30%.

### Claim 19 (depends on 2)

The composition of claim 2, wherein the concentration of alcohol is less than about 10%.

### Claim 20 (depends on 2)

The composition of claim 2, wherein the concentration of alcohol is from about 0.25% to about 5%.

### Claim 21 (depends on 2)

The composition of claim 2, wherein the alcohol is ethanol, and wherein the chelator is EDTA or CaEDTA.

### Claim 22 (depends on 1)

A method for reducing microbial organisms from a surface or preventing growth of microbial organisms comprising contacting the surface with the composition of claim 1.

### Claim at position 23

23-44. (canceled)

### Claim 45 (depends on 1)

A kit for disinfecting a surface to reduce microorganisms thereon, wherein the kit comprises the composition of claim 1, wherein the biguanide and the glycol ether are contained in separate containers or a single container.

### Claim at position 25

46-55. (canceled)

### Claim 56 (depends on 1)

A syringe, comprising a unit dose of a pharmacologically effective amount of the solution of claim 1.

### Claim 57 (depends on 1)

A vial, comprising a lyophilized unit dose of a pharmacologically effective amount of the solution of claim 1.

### Claim 58

An antimicrobial composition comprising at least one biguanide and one of the following:
a) deoxycholate; or
b) a combination of at least one chelator, at least one alcohol, and at least one alkylpolyglucoside.
